H. O. Rasul Et Al. , "Screening the possible anti-cancer constituents of Hibiscus rosa-sinensis flower to address mammalian target of rapamycin: an in silico molecular docking, HYDE scoring, dynamic studies, and pharmacokinetic prediction," MOLECULAR DIVERSITY , 2022
Rasul, H. O. Et Al. 2022. Screening the possible anti-cancer constituents of Hibiscus rosa-sinensis flower to address mammalian target of rapamycin: an in silico molecular docking, HYDE scoring, dynamic studies, and pharmacokinetic prediction. MOLECULAR DIVERSITY .
Rasul, H. O., Aziz, B. K., Ghafour, D. D., & KIVRAK, A., (2022). Screening the possible anti-cancer constituents of Hibiscus rosa-sinensis flower to address mammalian target of rapamycin: an in silico molecular docking, HYDE scoring, dynamic studies, and pharmacokinetic prediction. MOLECULAR DIVERSITY .
Rasul, Hezha Et Al. "Screening the possible anti-cancer constituents of Hibiscus rosa-sinensis flower to address mammalian target of rapamycin: an in silico molecular docking, HYDE scoring, dynamic studies, and pharmacokinetic prediction," MOLECULAR DIVERSITY , 2022
Rasul, Hezha O. Et Al. "Screening the possible anti-cancer constituents of Hibiscus rosa-sinensis flower to address mammalian target of rapamycin: an in silico molecular docking, HYDE scoring, dynamic studies, and pharmacokinetic prediction." MOLECULAR DIVERSITY , 2022
Rasul, H. O. Et Al. (2022) . "Screening the possible anti-cancer constituents of Hibiscus rosa-sinensis flower to address mammalian target of rapamycin: an in silico molecular docking, HYDE scoring, dynamic studies, and pharmacokinetic prediction." MOLECULAR DIVERSITY .
@article{article, author={Hezha O. Rasul Et Al. }, title={Screening the possible anti-cancer constituents of Hibiscus rosa-sinensis flower to address mammalian target of rapamycin: an in silico molecular docking, HYDE scoring, dynamic studies, and pharmacokinetic prediction}, journal={MOLECULAR DIVERSITY}, year=2022}